Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways

Yifei Lu, Yihan Zhang, Zhenyu Pan, Chao Yang, Lin Chen, Yuanyuan Wang, Dengfeng Xu, Hui Xia, Shaokang Wang, Shiqing Chen, Yoong Jun Hao and Guiju Sun

Nutrients, 2022, 14, 1094
DOI: 10.3390/nu14051094

Platycodi Radix Extract Prevents Hepatic Steatosis by Enhancing Bile Acid Synthesis in a High-Fat Diet-Induced Fatty Liver Mouse Model

Wooyoung Kim, Woon Hee Baek, Sung Ho Yun, Hayoung Lee, Mi Jeong Kim, Sang-Yeop Lee, Gun-Hwa Kim, Seung Il Kim, Hye Gwang Jeong and Edmond Changkyun Park

Nutrients, 2024, 16, 893
DOI: 10.3390/nu16060893

MicroRNA let-7f-5p regulates PI3K/AKT/COX2 signaling pathway in bacteria-induced pulmonary fibrosis via targeting of PIK3CA in forest musk deer

Wei Zhao, Jianguo Cheng, Yan Luo, Wenlong Fu, Lei Zhou, Xiang Wang, Yin Wang, Zexiao Yang, Xueping Yao, Meishen Ren, Zhijun Zhong, Xi Wu, Ziwei Ren and Yimeng Li

PeerJ, 2022, 10, e14097
DOI: 10.7717/peerj.14097

Silicon carbide nanoparticles induce pulmonary fibrosis by promoting macrophage apoptosis through parkin-mediated mitophagy disruption and the intervention effect of emodin

Sufang Wu, Xianglong Wu, Nuo Xu, Ze Li, Yang Dong, Chenxing Zhang, Qian Liu, Huang Chen, Lele Liu, Yanxin Hu, Gancen Zhang, Yunru Liu, Jin Xu and Aihua Gu

Journal of Hazardous Materials, 2026, 507, 141765
DOI: 10.1016/j.jhazmat.2026.141765

Yi-Fei-Tong-Bi Decoction Alleviates Bleomycin Induced Pulmonary Fibrosis in Mice

Kui Du, Xingjian Wen, Jie Zhu, Rui Liang, Lu Wang, Na Li and Qinghua Zou

DDDT, 2025, Volume 19, 3983
DOI: 10.2147/DDDT.S515368

Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases

Chao Yang, Limor Rubin, Xiyong Yu, Philip Lazarovici and Wenhua Zheng

Medicinal Research Reviews, 2024, 44, 1326
DOI: 10.1002/med.22014

The Mechanism and Effect of Autophagy, Apoptosis, and Pyroptosis on the Progression of Silicosis

Shiyi Tan and Shi Chen

IJMS, 2021, 22, 8110
DOI: 10.3390/ijms22158110

Cannabidiol suppresses silica-induced pulmonary inflammation and fibrosis through regulating NLRP3/TGF-β1/Smad2/3 pathway

Wei Shao, Jiazhen Zhang, Zongze Yao, Pan Zhao, Bo Li, Wenjian Tang and Jing Zhang

International Immunopharmacology, 2024, 142, 113088
DOI: 10.1016/j.intimp.2024.113088

Synthesis of 2D molybdenum disulfide nanoplatform with effective chemo-photothermal antifungal activities and extended shelf-life of fruits

Weiwei Zhang, Liangjun Yang, Hanghang Li, Ping Song, Wanzhen Li, Lin Gui, Kai Yang, Longbao Zhu, Yugui Tao and Fei Ge

Materials Chemistry and Physics, 2023, 296, 127350
DOI: 10.1016/j.matchemphys.2023.127350

Tryptanthrin alleviate lung fibrosis via suppression of MAPK/NF-κB and TGF-β1/SMAD signaling pathways in vitro and in vivo

Min Niu, Yong-Zhi Wang, Xiang-min Deng, Xin Wu, Zheng-Ying Hua and Ting-Ting Lv

Toxicology and Applied Pharmacology, 2025, 498, 117285
DOI: 10.1016/j.taap.2025.117285

Gracillin relieves pulmonary fibrosis by suppressing the STAT3 axis

Mengyao Xie, Lehe Yang, Jiayun Cheng, Hongyan Qu, Yanting Gu, Cheng Ding, Xiaomei Xu, Chengguang Zhao, Xiaoying Huang and Liangxing Wang

Journal of Ethnopharmacology, 2023, 316, 116704
DOI: 10.1016/j.jep.2023.116704

Traditional Herbal Plants and their Phytoconstituents Based Remedies for Respiratory Diseases: A Review

Luca Campbell

TORMJ, 2025, 19
DOI: 10.2174/0118743064341009241210045737

Mangostanin Derivatives as Novel and Orally Active Phosphodiesterase 4 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis with Improved Safety

Yi-You Huang, Jinhui Deng, Yi-Jing Tian, Jinhao Liang, Xi Xie, Yue Huang, Jiaqi Zhu, Ziran Zhu, Qian Zhou, Xixin He and Hai-Bin Luo

J. Med. Chem., 2021, 64, 13736
DOI: 10.1021/acs.jmedchem.1c01085

Pulmonary fibrosis: from mechanisms to therapies

Mengna Jiang, Wenxia Bu, Xuehai Wang, Jialing Ruan, Weijian Shi, Siqi Yu, Lizhen Huang, Peng Xue, Juan Tang, Xinyuan Zhao, Liling Su and Demin Cheng

J Transl Med, 2025, 23
DOI: 10.1186/s12967-025-06514-2

Pharmacologic Activities of Plant‐Derived Natural Products on Respiratory Diseases and Inflammations

Deepak Timalsina, Krishna Prasad Pokhrel, Deepti Bhusal and Kazim Husain

BioMed Research International, 2021, 2021
DOI: 10.1155/2021/1636816

Lysionotin attenuates bleomycin-induced pulmonary fibrosis by activating AMPK/Nrf2 pathway

Xiaohua Zhang, Dayan Xiong, Lang Deng, Rui Qian, Siyuan Tang, Wei Liu, Ying Li, Lang Liu, Weixi Xie and Miao Lin

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-17045-7

Study of paraquat-induced pulmonary fibrosis using biomimetic micro-lung chips

Jingjing Xia, Zhuo Xiong, Jiaxuan Guo, Yongan Wang, Yuan Luo, Yangyang Sun, Zhongwei Guo, Bingchuan Lu, Ting Zhang and Wei Sun

Biofabrication, 2023, 15, 014104
DOI: 10.1088/1758-5090/ac999e

Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation

Chunyu Guo, Cheng Zhang, Zhengmei Xia, Bingdong Song, Weirong Hu, Yingying Cui, Yanni Xue, Mizhen Xia, Dexiang Xu, Shichen Zhang and Jun Fang

Journal of Controlled Release, 2022, 341, 566
DOI: 10.1016/j.jconrel.2021.11.047

Tocotrienol-Rich Fractions Offer Potential to Suppress Pulmonary Fibrosis Progression

Yifei Lu, Yihan Zhang, Dengfeng Xu, Yuanyuan Wang, Da Pan, Pei Wang, Jiayue Xia, Shiyu Yin, Wang Liao, Shaokang Wang and Guiju Sun

IJMS, 2022, 23, 14331
DOI: 10.3390/ijms232214331

Resveratrol Alleviates Liver Fibrosis Induced by Long-Term Inorganic Mercury Exposure through Activating the Sirt1/PGC-1α Signaling Pathway

Siyu Li, Biqi Han, Jiayi Li, Zhanjun Lv, Huijie Jiang, Yunfeng Liu, Xu Yang, Jingjing Lu and Zhigang Zhang

J. Agric. Food Chem., 2024, 72, 15985
DOI: 10.1021/acs.jafc.4c02349

Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4/NF-κB pathway

Huan Xu, Kaixuan Ma, Ziting Ma, Tianyu Zhuang and Ling Lin

Front. Immunol., 2025, 16
DOI: 10.3389/fimmu.2025.1558903

Emerging molecular targets and natural therapeutics for idiopathic pulmonary fibrosis: Insights into mechanisms, risks, and COVID-19 links

Rashmi Singh, Aditya Kumar Pradhan, Dipanjan Roy, Mansi Arya, Rudra Chakravarti, Debrupa Dutta, Anirban Kundu, Swapnesh Bhaduri, Prabhjot Singh, Kazi Tawsif Ahmed and Bireswar Bhattacharya

Respiratory Medicine, 2025, 250, 108519
DOI: 10.1016/j.rmed.2025.108519

Specneuzhenide improves bleomycin-induced pulmonary fibrosis in mice via AMPK-dependent reduction of PD-L1

Yanliang Wu, Wen Shi, Haini Li, Chang Liu, Kuniyoshi Shimizu, Renshi Li and Chaofeng Zhang

Phytomedicine, 2024, 128, 155318
DOI: 10.1016/j.phymed.2023.155318

Fibroblast PI3K/AKT signaling and extracellular matrix homeostasis: mechanisms, targets, and delivery challenges

Chunyun Fang, Zitao Zeng, Bin Ni, Xiaochun Wen, Zhipeng Fang, Junrong Zou and Guoxi Zhang

Front. Cell Dev. Biol., 2025, 13
DOI: 10.3389/fcell.2025.1681875

Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis

Junsheng Liu, Liu Liu, Guangwen Zhang and Xichun Peng

International Journal of Biological Macromolecules, 2021, 189, 346
DOI: 10.1016/j.ijbiomac.2021.08.139

Inhalation of Tetrandrine Liposomes for The Treatment of Bleomycin Induced Idiopathic Pulmonary Fibrosis

Yinmei Liang, Ling Sun, Rong Feng, Xingxing Han, Xinai Ma, Xiaomin Deng, Mengdi Cheng, Jinjun Shan, Wei Li and Tingming Fu

SSRN Journal, 2022
DOI: 10.2139/ssrn.4088128

Apocarotenoids from the fresh roots of Rehmannia glutinosa and their anti-pulmonary fibrosis activity

Xiang-Da Li, Yan-Gang Cao, Yu-Han Zhang, Ying-Jie Ren, Meng-Nan Zeng, Yan-Ling Liu, Xu Chen, Xin-Yi Ma, Bing-Xian Zhao, Xiao-Ke Zheng and Wei-Sheng Feng

Fitoterapia, 2024, 179, 106247
DOI: 10.1016/j.fitote.2024.106247

Design, synthesis and in vitro assessment of di-/tri-methoxy-aryl-substituted mono-spiro-1,2,4,5-tetraoxanes for antiplasmodial and anticancer use

Mohit K. Tiwari, Malgorzata Kucinska, Agnieszka Zgoła-Grześkowiak, Marziyeh Raeispour, Marek Murias, Philippe Grellier, Łukasz Marczak and Tomasz Goslinski

European Journal of Medicinal Chemistry, 2025, 300, 118159
DOI: 10.1016/j.ejmech.2025.118159

Gambogic acid suppresses pancreatic fibrosis via inhibiting YAP1-mediated activation of pancreatic stellate cells

Wei Li, Guangming Li, Yi Wang and Yuxin Zhou

Chinese Journal of Natural Medicines, 2026, 24, 89
DOI: 10.1016/S1875-5364(26)61079-5

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

Mahbub Hasan, Nidhan Chandra Paul, Shamrat Kumar Paul, Abu Saim Mohammad Saikat, Hafeza Akter, Manoj Mandal and Sang-Suk Lee

Molecules, 2022, 27, 1481
DOI: 10.3390/molecules27051481

Corydaline binds to a druggable pocket of hEAG1 channel and inhibits hepatic carcinoma cell viability

Biao Ma, Sai Shi, Shuxi Ren, Chang Qu, Zhen Zhao and Hailong An

European Journal of Pharmacology, 2024, 962, 176240
DOI: 10.1016/j.ejphar.2023.176240

Experimental and clinical insights into the therapeutic potential of Berberis vulgaris and its bioactive constituents in respiratory, allergic, and immunological disorders: a comprehensive review

Farzaneh Shakeri, Sahar Kiani, Maryam Moradi Binabaj, Mohammad Hossein Ghalibaf, Golnoosh Rahimi, Mahboobeh Ghasemzadeh Rahbardar and Mohammad Hossein Boskabady

Naunyn-Schmiedeberg's Arch Pharmacol, 2026
DOI: 10.1007/s00210-025-04939-6

Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway

Jiang Li, Qian Wei, Ke Song, Youxin Wang, Yuxin Yang, Miao Li, Jiaying Yu, Guangxu Su, Luyuan Peng, Bendong Fu and Pengfei Yi

Front. Pharmacol., 2023, 14
DOI: 10.3389/fphar.2023.1247800

Atractylodin ameliorates bleomycin-induced pulmonary inflammation and fibrosis in mice

Zhenhui Wu, Jinhua Fu, Shufang Zhang, Yihao Huang, Jiang Xu, Miaoxin Zhu, Shanghua Chen, Liang Ye, Meigui You, Jie Wang, Xue Yi and Yaping Xu

Pharmacological Research - Modern Chinese Medicine, 2023, 8, 100285
DOI: 10.1016/j.prmcm.2023.100285

Emerging Trends in Phytochemical Nanomedicines for Lung Inflammation and Fibrosis Management

Dhanya M. Shetty, Akarsha Balnadupete, Yashodhar P. Bhandary, Saji Uthaman and Renjith P. Johnson

Adv Healthcare Materials, 2026
DOI: 10.1002/adhm.202504927

The Role of Nrf2 in Pulmonary Fibrosis: Molecular Mechanisms and Treatment Approaches

Yu Wang, Juan Wei, Huimin Deng, Li Zheng, Hao Yang and Xin Lv

Antioxidants, 2022, 11, 1685
DOI: 10.3390/antiox11091685

Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA

Peng Cheng, Yongbin Wang, Qian Wu, Huanan Zhang, WanLi Fang and Feifei Feng

Biomedicine & Pharmacotherapy, 2024, 177, 117014
DOI: 10.1016/j.biopha.2024.117014

Unraveling miRNA-mediated TGF-β/hedgehog Signaling in bleomycin-induced pulmonary fibrosis: targeting inflammation–fibrosis crosstalk with candesartan and chlorogenic acid

Aya Aly A. El-Shazly, Mai A. Abd-Elmawla, Yasmin S. Abulfadl, Nesreen Nabil Omar and Sherine M. Rizk

Bioorganic Chemistry, 2026, 173, 109655
DOI: 10.1016/j.bioorg.2026.109655

Searching for the Holy Grail − Highly Potent Bridged Endoperoxides for Targeted Cancer Therapy

Mohit K. Tiwari and Tomasz Goslinski

Bioorganic Chemistry, 2024, 153, 107893
DOI: 10.1016/j.bioorg.2024.107893

Pathological Mechanisms of Radiation-Induced Lung Injury and Novel Nano-Drug Delivery Therapeutic Strategies

Xiaohuo Zhang, Zhiruo Zhang, Mi Huang, Yufan Jin, Youming Huang, Peng Ji and Zhenchao Ma

IJN, 2025, Volume 20, 12431
DOI: 10.2147/IJN.S551477

Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification

Jie Li, Yi Wang, Rui Wang, Meng-Yu Wu, Jing Shan, Ying-Chi Zhang and Hai-Ming Xu

Heliyon, 2022, 8, e10201
DOI: 10.1016/j.heliyon.2022.e10201

Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer

Liyan Yang and Zhonglei Wang

Biomedicines, 2021, 9, 689
DOI: 10.3390/biomedicines9060689

Comparative study of adipose tissue derived mesenchymal stem cells with rapamycin on paraquat-induced acute lung injury and pulmonary fibrosis in a mouse model: histological and biochemical study

Heba Fikry, Lobna A. Saleh and Doaa R. Sadek

Stem Cell Res Ther, 2025, 16
DOI: 10.1186/s13287-025-04498-w

Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features

You Wu, Ke Tang, Chunzheng Wang, Hao Song, Fanfan Zhou and Ying Guo

Acta Pharmaceutica Sinica B, 2025, 15, 1344
DOI: 10.1016/j.apsb.2025.02.009

Liensinine, a Novel and Food-Derived Compound, Exerts Potent Antihepatoma Efficacy via Inhibiting the Kv10.1 Channel

Biao Ma, Sai Shi, Wei Guo, Hailin Zhang, Zhen Zhao and Hailong An

J. Agric. Food Chem., 2024, 72, 4689
DOI: 10.1021/acs.jafc.3c06142

A comprehensive overview of Artemisinin and its derivatives as anticancer agents

Zi-wei Zeng, Di Chen, Lei Chen, Bin He and Yan Li

European Journal of Medicinal Chemistry, 2023, 247, 115000
DOI: 10.1016/j.ejmech.2022.115000

Integrated mRNA–miRNA transcriptome profiling of blood immune responses potentially related to pulmonary fibrosis in forest musk deer

Wen-Hua Qi, Li-Fan Hu, Yu-Jiawei Gu, Xiao-Yan Zhang, Xue-Mei Jiang, Wu-Jiao Li, Jun-Sheng Qi, Guo-Sheng Xiao and Hang Jie

Front. Immunol., 2024, 15
DOI: 10.3389/fimmu.2024.1404108

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

Cristina Estornut, Javier Milara, María Amparo Bayarri, Nada Belhadj and Julio Cortijo

Front. Pharmacol., 2022, 12
DOI: 10.3389/fphar.2021.794997

18β-Glycyrrhetinic acid monoglucuronide (GAMG) alleviates single-walled carbon nanotubes (SWCNT)-induced lung inflammation and fibrosis in mice through PI3K/AKT/NF-κB signaling pathway

Xiao-Li Zhang, Bo Li, Xiang Zhang, Jiaojiao Zhu, Yunfeng Xie, Tong Shen, Wenjian Tang and Jing Zhang

Ecotoxicology and Environmental Safety, 2022, 242, 113858
DOI: 10.1016/j.ecoenv.2022.113858

Regulatory Cues in Pulmonary Fibrosis—With Emphasis on the AIM2 Inflammasome

Yu-Hsin Tseng, I-Chen Chen, Wan-Chun Li and Jong-Hau Hsu

IJMS, 2023, 24, 10876
DOI: 10.3390/ijms241310876

Assessment of the protective effects of tannic acid against bleomycin-induced lung fibrosis in rats

Amir Siahpoosh, Narges Atefipour, Mohammadreza Momeni Qomi, Mehdi Goudarzi, Laya Sadat Khorsandi, Rezvan Hafezi and Ali Reza Malayeri

Biotechnic & Histochemistry, 2026, 101, 161
DOI: 10.1080/10520295.2025.2611824

A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs

Ya-long Feng

CPD, 2024, 30, 3009
DOI: 10.2174/0113816128310724240730072626

Inhalation of tetrandrine liposomes for the treatment of bleomycin induced idiopathic pulmonary fibrosis

Yinmei Liang, Ling Sun, Xinai Ma, Rong Feng, Xingxing Han, Xiaomin Deng, Mengdi Cheng, Jinjun Shan, Wei Li and Tingming Fu

Journal of Drug Delivery Science and Technology, 2022, 74, 103492
DOI: 10.1016/j.jddst.2022.103492

Revealing a new target: Celastrol alleviates pulmonary fibrosis by inhibiting PCAF

Libo Wang, Fei Lin, Junwei Liu, Zhichao Jia, Mingyang Zhu, Yuan Liu, Yongheng Li and Lin Yang

Bioorganic Chemistry, 2025, 163, 108722
DOI: 10.1016/j.bioorg.2025.108722

The Peptide DH α-(4-pentenyl)-ANPQIR-NH2 Exhibits Antifibrotic Activity in Multiple Pulmonary Fibrosis Models Induced by Particulate and Soluble Chemical Fibrogenic Agents

Jieru Li, Bochuan Deng, Jiao Zhang, Xiang Zhang, Lu Cheng, Guofeng Li, Ping Su, Xiaokang Miao, Wenle Yang, Junqiu Xie and Rui Wang

The Journal of Pharmacology and Experimental Therapeutics, 2024, 388, 701
DOI: 10.1124/jpet.123.001849